Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. IPX
stocks logo

IPX

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Intellectia AI SwingMax
Intellectia AI SwingMax
Wall Street analysts forecast IPX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for IPX is 74.00 USD with a low forecast of 74.00 USD and a high forecast of 74.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
Wall Street analysts forecast IPX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for IPX is 74.00 USD with a low forecast of 74.00 USD and a high forecast of 74.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 33.480
sliders
Low
74.00
Averages
74.00
High
74.00
Current: 33.480
sliders
Low
74.00
Averages
74.00
High
74.00
Spruce Point Capital
downgrade
2025-11-12
Reason
Spruce Point Capital
Price Target
2025-11-12
downgrade
Reason
Spruce Point Capital, in a research note, said that after conducting a forensic review of IperionX and its ambitions of becoming a vertically integrated producer of titanium powders and products, the firm believes that investor expectations are too high, and it faces significant challenges in commercial efforts that may not be fully reflected in its valuation. Spruce Point also expressed concerns with the accuracy of its financial reporting and says it does not believe the end markets to be attractive or that its highly promoted HAMR process is likely to "revolutionize" the industry. Based on the firm's analysis, Spruce Point advises investors to exercise caution because the shares may be significantly overvalued, with potential downside risk of 70% - 95% under certain scenarios. Reference Link
Roth Capital
Buy
maintain
$64 -> $74
2025-10-01
Reason
Roth Capital
Price Target
$64 -> $74
2025-10-01
maintain
Buy
Reason
Roth Capital raised the firm's price target on IperionX to $74 from $64 and keeps a Buy rating on the shares. The firm cites the company's FY25 results and the receipt of additional government funding as part of its existing $47.1M award, the analyst tells investors in a research note. Roth adds that its higher price target reflects lower future dilution assumptions and a higher multiple on 2029 EBITDA.
Roth Capital
Joe Reagor
Buy
initiated
$64
2025-08-20
Reason
Roth Capital
Joe Reagor
Price Target
$64
2025-08-20
initiated
Buy
Reason
Roth Capital analyst Joe Reagor initiated coverage of IperionX with a Buy rating and $64 price target. The company has a "game changing" technology for producing titanium products, the analyst tells investors in a research note. Roth believes IperionX will expand production in the coming years and it sees potential upside to its price target if IperionX can compete in the stainless steel and aluminum markets.
Alliance Global Partners
Jake Sekelsky
Buy
maintain
$32 -> $35
2025-06-06
Reason
Alliance Global Partners
Jake Sekelsky
Price Target
$32 -> $35
2025-06-06
maintain
Buy
Reason
Alliance Global Partners analyst Jake Sekelsky raised the firm's price target on IperionX to $35 from $32 and keeps a Buy rating on the shares. The company recently announced the receipt of a United States Department of Defense contract for up to $99M, which indicates IperionX's status as a near-term commercial supplier of domestic titanium products, the analyst tells investors in a research note. The firm views the award as further validation that the company is on the cusp of commercializing its HAMR titanium processing technology and transitioning to serving as a key player in the on-shoring of the titanium supply chain in the U.S.
B. Riley Securities
Lucas Pipes
Strong Buy
Maintains
$30 → $28
2025-04-22
Reason
B. Riley Securities
Lucas Pipes
Price Target
$30 → $28
2025-04-22
Maintains
Strong Buy
Reason
B. Riley lowered the firm's price target on IperionX to $28 from $30 and keeps a Buy rating on the shares. IperionX is scaling up titanium manufacturing at its Virginia campus, with full operational capacity expected by mid-2025, although Riley now assumes a more conservative ramp, the analyst tells investors in a research note.
See All Ratings

Valuation Metrics

The current forward P/E ratio for Iperionx Ltd (IPX.O) is -446.40, compared to its 5-year average forward P/E of -64.21. For a more detailed relative valuation and DCF analysis to assess Iperionx Ltd 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-64.21
Current PE
-446.40
Overvalued PE
132.04
Undervalued PE
-260.46

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-22.07
Current EV/EBITDA
-76.15
Overvalued EV/EBITDA
12.34
Undervalued EV/EBITDA
-56.48

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
33.67
Current PS
86.78
Overvalued PS
78.40
Undervalued PS
-11.06
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
AI Stock Picker
AI Stock Picker

IPX News & Events

Events Timeline

(ET)
2025-11-17
08:37:12
IperionX Addresses Report from Spruce Point Short Seller
select
2025-10-30 (ET)
2025-10-30
08:39:13
IperionX Announces $79.2 Million in Cash Reserves as of September 30
select
2025-09-26 (ET)
2025-09-26
08:37:01
IperionX Secures $25 Million in U.S. Funding to Boost Titanium Production
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
2.0
11-18Benzinga
Major Stocks Including Helmerich and Payne, Invivyd, and Home Depot Decline in Tuesday's Pre-Market Trading

  • U.S. Stock Futures: U.S. stock futures are down, with Dow futures dropping approximately 200 points on Tuesday morning.

  • Helmerich and Payne Inc: The company reported a fourth-quarter loss of 1 cent per share despite quarterly sales of $1.012 billion, leading to a 7% drop in its shares during pre-market trading.

  • Other Stocks Declining: Several other stocks, including Alpha Technology Group Ltd and Invivyd Inc, experienced significant declines in pre-market trading, with drops of 19% and 13.4%, respectively.

  • Home Depot's Performance: Home Depot's shares fell 2% after reporting worse-than-expected third-quarter adjusted EPS and lowering its FY25 adjusted EPS outlook.

[object Object]
Preview
2.0
11-12SeekingAlpha
IperionX Declines Following New Short Recommendation from Spruce Point

  • Stock Performance: IperionX (IPX) ADRs fell by 5% following a short report from Spruce Point, which disclosed its short position in the company.

  • Company Response: IperionX has not yet responded to requests for comment from Seeking Alpha regarding the short report.

  • Government Funding: The company recently secured $12.5 million in funding from the U.S. government to expand its titanium production capabilities.

  • Financial Insights: Additional financial information and historical earnings data for IperionX Limited are available through Seeking Alpha’s Quant Rating.

[object Object]
Preview
7.0
11-12Globenewswire
Investor Notice: Holzer & Holzer, LLC Launches Investigation into IperionX Limited (IPX)

  • Investigation Announcement: Holzer & Holzer, LLC is investigating IperionX Limited for potential violations of federal securities laws following a report by Spruce Point that raised concerns about the company's financial reporting and its impact on operating cash flows.

  • Stock Price Impact: The release of the short report by Spruce Point led to a decline in IperionX's stock price, prompting calls for affected investors to seek legal advice regarding their rights.

  • Legal Support Offered: Investors who purchased IperionX stock and experienced losses are encouraged to contact Holzer & Holzer for legal assistance, with contact details provided for inquiries.

  • Firm's Background: Holzer & Holzer, LLC is a well-regarded securities litigation law firm that has successfully represented shareholders in various cases, recovering significant amounts for those affected by corporate misconduct.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Iperionx Ltd (IPX) stock price today?

The current price of IPX is 33.48 USD — it has increased 1.41 % in the last trading day.

arrow icon

What is Iperionx Ltd (IPX)'s business?

IperionX Limited is a titanium metal and critical materials company that uses patented metal technologies to produce high performance titanium alloys, from titanium minerals or scrap titanium, at lower energy and carbon emissions. It is engaged in the exploration and evaluation of its mineral properties in the United States and the research, development, and commercialization of its associated metals technologies to support an integrated titanium processing operation. It holds a 100% interest in the Titan Project, covering more than 11,000 acres of mineral properties in western Tennessee, which it considers prospective for critical minerals including titanium, rare earth elements, silica sand and zircon. Its titanium metal and critical minerals are essential for advanced United States industries including space, aerospace, defense, consumer electronics, hydrogen, electric vehicles and additive manufacturing. It has commissioned hydrogen assisted metallothermic reduction furnace.

arrow icon

What is the price predicton of IPX Stock?

Wall Street analysts forecast IPX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for IPX is 74.00 USD with a low forecast of 74.00 USD and a high forecast of 74.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Iperionx Ltd (IPX)'s revenue for the last quarter?

Iperionx Ltd revenue for the last quarter amounts to NaN USD, decreased % YoY.

arrow icon

What is Iperionx Ltd (IPX)'s earnings per share (EPS) for the last quarter?

Iperionx Ltd. EPS for the last quarter amounts to USD, decreased % YoY.

arrow icon

What changes have occurred in the market's expectations for Iperionx Ltd (IPX)'s fundamentals?

The market is revising No Change the revenue expectations for IPX for , with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by -31.01%.
arrow icon

How many employees does Iperionx Ltd (IPX). have?

Iperionx Ltd (IPX) has 30 emplpoyees as of December 05 2025.

arrow icon

What is Iperionx Ltd (IPX) market cap?

Today IPX has the market capitalization of 1.10B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free